Decline of anti-DP107 antibody associated with clinical progression

被引:9
作者
Hattori, T [1 ]
Komoda, H
Pahwa, S
Tateyama, M
Zhang, X
Xu, Y
Oguma, S
Tamamura, H
Fujii, N
Fukutake, K
Uchiyama, T
机构
[1] Kyoto Univ, Inst Virus Res, Lab Virus Immunol, Sakyo Ku, Kyoto 606, Japan
[2] NYU, Sch Med, N Shore Univ Hosp, Manhasset, NY 11030 USA
[3] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 606, Japan
[4] Kyoto Univ Hosp, Dept Hematol, Kyoto, Japan
[5] Tokyo Sch Med, Dept Clin Pathol, Shijyuku Ku, Tokyo 160, Japan
关键词
D O I
10.1097/00002030-199812000-00023
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1557 / 1559
页数:3
相关论文
共 6 条
[1]   Core structure of gp41 from the HIV envelope glycoprotein [J].
Chan, DC ;
Fass, D ;
Berger, JM ;
Kim, PS .
CELL, 1997, 89 (02) :263-273
[2]   IMMUNOLOGICAL CHARACTERISTICS OF HIV-INFECTED CHILDREN - RELATIONSHIP TO AGE, CD4 COUNTS, DISEASE PROGRESSION, AND SURVIVAL [J].
CHIRMULE, N ;
LESSER, M ;
GUPTA, A ;
RAVIPATI, M ;
KOHN, N ;
PAHWA, S .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (10) :1209-1219
[3]   A GAG-ENV HYBRID PROTEIN OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I AND ITS APPLICATION TO SERUM DIAGNOSIS [J].
KUGA, T ;
YAMASAKI, M ;
SEKINE, S ;
FUKUI, M ;
YOKOO, Y ;
ITOH, S ;
YOSHIDA, M ;
HATTORI, T ;
TAKATSUKI, K .
JAPANESE JOURNAL OF CANCER RESEARCH, 1988, 79 (11) :1168-1173
[4]   THE SYNTHETIC [TYR(5,12),LYS(7)]-POLYPHEMUSIN-II PEPTIDE (T22) BINDS TO THE CD4 CELL-SURFACE MOLECULE [J].
WEEKS, BS ;
NOMIZU, M ;
OTAKA, A ;
WESTON, CA ;
OKUSU, A ;
TAMAMURA, H ;
YAMAMOTO, N ;
FUJII, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 215 (02) :626-631
[5]   Atomic structure of the ectodomain from HIV-1 gp41 [J].
Weissenhorn, W ;
Dessen, A ;
Harrison, SC ;
Skehel, JJ ;
Wiley, DC .
NATURE, 1997, 387 (6631) :426-430
[6]   THE INHIBITORY ACTIVITY OF AN HIV TYPE-1 PEPTIDE CORRELATES WITH ITS ABILITY TO INTERACT WITH A LEUCINE-ZIPPER STRUCTURE [J].
WILD, C ;
GREENWELL, T ;
SHUGARS, D ;
RIMSKYCLARKE, L ;
MATTHEWS, T .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (03) :323-325